Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Nov 9;72(12):1669–1677. doi: 10.1002/acr.24089

Table 1.

Participant descriptive statistics by group

Total N=100 FM N=50 Non FM N=50

Age, years

Mean (SD) 45.1 (13.9) 44.9 (13.9) 45.2 (14.0)
Range 18–73 20–70 18–73

Female, N (%) 88 (88%) 44 (88%) 44 (88%)

Education
Years, mean (SD) 15.7 (2.0) 15.7 (2.0) 15.8 (2.0)

Employment Status*
Full-time 19 (38) 21 (42)
Part-time 10 (20) 17 (34)
Student 4 (8) 5 (10)
Unemployed 20 (40) 11 (22)

Race

White 81 (81%) 43 (86%) 38 (76%)
Black 13 (13%) 5 (10%) 8 (16%)
Bi/multi-racial 3 (3%) 2 (4%) 1 (2%)
Asian 3 (3%) 0 (0%) 3 (6%)

Medication Categories, N (%)
Opioid 16 (32%) 1 (2%)

SSRI 21 (42%) 9 (18%)

Tricyclic antidepressant 5 (10%) 0 (0%)

Pregabalin/gabapentin 8 (16%) 2 (4%)

Benzodiazepine 9 (18%) 2 (4%)

Sleep Aid 13 (26%) 0 (0%)

Symptoms (mean, SD)

PROMIS pain intensity T- score 45.0 (11.4) 54.3 (6.1) 35.6 (6.8)

PROMIS fatigue experience T-score 55.0 (13.8) 65.9 (7.0) 44.1 (9.5)

Patient Health Questionnaire-8 (total score) 6.2 (5.9) 10.6 (5.2) 1.8 (2.1)

Note. Percentages may total to >100 because participants could select more than one category. SSRI= Selective serotonin reuptake inhibitors